CytoDyn, Inc.



 

Investors

Forward-looking statements are statements that are not historical facts. The Company's management makes forward-looking statements concerning the Company's expected future operations, performance and other developments. These forward-looking statements are necessarily estimates based upon current information and projections and involve a number of risks and uncertainties, including but not limited to, the failure of preliminary results from scientific studies to reflect the results from more comprehensive studies. There can be no assurance that such risks and uncertainties, or other factors, will not affect the accuracy of such forward-looking statements. It is impossible to identify all factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, victimization by white-collar offenders, and the effects of adverse publicity, litigation, competition, and other factors that may be identified from time to time in the Company's announcements.

 

CYDY Stock Quote 

Past performance does not guarantee future results. Historic SEC  Filings
 
Letter to Shareholders
Los Angeles Meeting July 3, 2008
CytoDyn's CEO and COO met with Los Angeles shareholders on July 3, 2008 to answer questions about the Company's plans and progress, as had been previously reported on CytoDyn's web site and in news releases. The meeting was chaired by the Company's independent IR consultant, Don Donchuanchom. One of about 200 patients who claim to have been rescued by Cytolin© prior to the advent of effective antiretroviral therapy volunteered to tell his personal story and had brought along his medical records as confirmation. CytoDyn has held such meetings from time to time in Southern and Northern California and in other select locations. Photo Gallery